Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation
- PMID: 9312164
- PMCID: PMC508349
- DOI: 10.1172/JCI119691
Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation
Abstract
B cells expressing the CD5 cell surface antigen are involved in certain B cell malignancies and autoimmune diseases. From studies in the mouse, it emerged that CD5+ B cells represent a separate lineage of B lymphocytes that, in contrast to conventional (CD5-) B cells, are not driven into T cell-dependent immune responses in which rearranged variable (V) region genes are diversified by somatic hypermutation. Against this background it came as a surprise that human disease-involved CD5-positive autoreactive B cells as well as B cell chronic lymphocytic leukemias can harbor somatically mutated V region genes. Recent V gene analyses on CD5+ B cells in healthy adults did not give rise to a clear picture about the fraction of somatically mutated among all CD5+ B cells. In this work we used a molecular single-cell analysis to determine reliably the frequency of mutated CD5+ B cells in healthy humans: single, kappa light chain-expressing CD5+ peripheral blood B cells were isolated by flow cytometry, and rearranged Vkappa genes were amplified by PCR. From one donor, CD5+CD19+ B cells were analyzed. Since CD5+ B cells were found among IgM+IgD+ and IgM+IgD- cells (but almost not among class-switched cells) from two other donors, individual cells corresponding to these IgM-expressing subsets were investigated separately. The sequence analysis of rearranged Vkappa genes revealed that most if not all CD5+ B cells in healthy humans carry unmutated V region genes. From one of the donors, a novel polymorphic Jkappa2 gene segment was identified. To explain the discrepancy between the frequent occurrence of disease-associated somatically mutated CD5+ B cells and the low incidence or absence of somatic mutation in normal CD5+ B cells, we speculate that CD5+ B cells usually do not participate in germinal center reactions, but if they occasionally do so, they may be at an increased risk to become involved in autoimmune diseases or B cell malignancies.
Similar articles
-
The CD5+ B-cell.Int J Biochem Cell Biol. 2004 Nov;36(11):2105-11. doi: 10.1016/j.biocel.2004.05.017. Int J Biochem Cell Biol. 2004. PMID: 15313456 Review.
-
Somatic hypermutation and B-cell lymphoma.Philos Trans R Soc Lond B Biol Sci. 2001 Jan 29;356(1405):73-82. doi: 10.1098/rstb.2000.0751. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11205334 Free PMC article. Review.
-
Monoclonal IgM rheumatoid factor secreted by CD5-negative B cells during mixed cryoglobulinemia. Evidence for somatic mutations and intraclonal diversity of the expressed VH region gene.J Immunol. 1995 Jan 1;154(1):413-21. J Immunol. 1995. PMID: 7527818
-
Evidence that the V kappa III gene usage is nonstochastic in both adult and newborn peripheral B cells and that peripheral CD5+ adult B cells are oligoclonal.J Clin Invest. 1994 May;93(5):2093-105. doi: 10.1172/JCI117204. J Clin Invest. 1994. PMID: 7514192 Free PMC article.
-
Peripheral human CD5+ and CD5- B cells may express somatically mutated VH5- and VH6-encoded IgM receptors.J Immunol. 1993 Dec 15;151(12):6891-9. J Immunol. 1993. PMID: 7505018
Cited by
-
Single-Cell Transcriptomic Analyses Define Distinct Peripheral B Cell Subsets and Discrete Development Pathways.Front Immunol. 2021 Mar 18;12:602539. doi: 10.3389/fimmu.2021.602539. eCollection 2021. Front Immunol. 2021. PMID: 33815362 Free PMC article.
-
Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.Front Immunol. 2018 Apr 4;9:683. doi: 10.3389/fimmu.2018.00683. eCollection 2018. Front Immunol. 2018. PMID: 29670635 Free PMC article. Review.
-
Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.Cancer Med. 2017 Dec;6(12):2984-2997. doi: 10.1002/cam4.1257. Epub 2017 Nov 10. Cancer Med. 2017. PMID: 29125235 Free PMC article.
-
Cellular origin and pathophysiology of chronic lymphocytic leukemia.J Exp Med. 2012 Nov 19;209(12):2183-98. doi: 10.1084/jem.20120833. Epub 2012 Oct 22. J Exp Med. 2012. PMID: 23091163 Free PMC article.
-
Purification and identification of cell surface antigens using lamprey monoclonal antibodies.J Immunol Methods. 2012 Dec 14;386(1-2):43-9. doi: 10.1016/j.jim.2012.08.016. Epub 2012 Sep 4. J Immunol Methods. 2012. PMID: 22964555 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions